Terug
Dagbereik
€ 104,91
€ 104,91
52-Weeksbereik
€ 38,81
€ 104,98
Volume
21.562.141
50D / 200D Gem.
€ 103,02
/
€ 74,29
Vorige Slotkoers
€ 104,91
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -96,3 | 0,2 |
| P/B | 8,3 | 3,0 |
| ROE % | -8,7 | 3,6 |
| Net Margin % | -6,4 | 3,8 |
| Rev Growth 5Y % | 16,4 | 9,9 |
| D/E | 1,1 | 0,2 |
Koersdoel Analisten
Hold
€ 103,18
-1.6%
Low: € 85,00
High: € 105,00
Forward K/W
582,83
Forward WPA
€ 0,18
WPA Groei (sch.)
+0,0%
Omzet Sch.
3,69B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 3,13
€ 2,82 – € 3,28
|
5,12B | 1 |
| FY2029 |
€ 2,09
€ 1,88 – € 2,18
|
4,93B | 1 |
| FY2028 |
€ 1,74
€ 0,94 – € 2,41
|
4,60B | 5 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-13 | -€ 0,11 | -€ 0,21 | -94,6% |
| 2025-11-03 | -€ 0,06 | € 0,24 | +492,0% |
| 2025-08-06 | -€ 0,02 | € 0,22 | +1200,0% |
| 2025-05-01 | -€ 0,37 | -€ 0,21 | +43,2% |
| 2025-02-19 | -€ 0,29 | -€ 0,06 | +79,3% |
| 2024-11-05 | -€ 0,20 | -€ 0,21 | -7,2% |
| 2024-07-31 | -€ 0,37 | -€ 0,09 | +75,7% |
| 2024-05-08 | -€ 0,48 | -€ 0,50 | -5,3% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue grew 16,43% annually over 5 years — strong growth
Generating 356,78M in free cash flow
Capital efficient — spends only 4,15% of revenue on capex
Groei
Revenue Growth (5Y)
16,43%
Revenue (1Y)17,69%
Earnings (1Y)N/A
FCF Growth (3Y)234,28%
Kwaliteit
Return on Equity
-8,66%
ROIC-1,51%
Net Margin-6,40%
Op. Margin-3,05%
Veiligheid
Debt / Equity
1,05
Current Ratio2,43
Interest Coverage-3,01
Waardering
P/E Ratio
-96,30
Forward P/E582,83
P/B Ratio8,34
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 17,69% | Revenue Growth (3Y) | 13,97% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 16,43% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3,25B | Net Income (TTM) | -207,95M |
| ROE | -8,66% | ROA | -3,55% |
| Gross Margin | 69,69% | Operating Margin | -3,05% |
| Net Margin | -6,40% | Free Cash Flow (TTM) | 356,78M |
| ROIC | -1,51% | FCF Growth (3Y) | 234,28% |
| Safety | |||
| Debt / Equity | 1,05 | Current Ratio | 2,43 |
| Interest Coverage | -3,01 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -96,30 | Forward P/E | 582,83 |
| P/B Ratio | 8,34 | P/S Ratio | 6,17 |
| PEG Ratio | 1,15 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | 19,51 |
| Forward P/S | 5,42 | Fwd Earnings Yield | 0,17% |
| FCF Yield | 1,78% | ||
| Market Cap | 20,03B | Enterprise Value | 21,59B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3,25B | 2,76B | 2,50B | 2,08B | 1,77B |
| Net Income | -207,95M | -1,03B | -204,15M | -623,51M | -595,63M |
| EPS (Diluted) | -1,10 | -5,59 | -1,13 | -3,54 | -3,48 |
| Gross Profit | 2,26B | 1,92B | 1,76B | 1,42B | 1,31B |
| Operating Income | -99,08M | -1,05B | -215,01M | -593,51M | -855,68M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5,86B | 5,93B | 6,47B | 6,23B | 6,68B |
| Total Liabilities | 3,46B | 3,53B | 3,33B | 3,18B | 3,30B |
| Shareholders' Equity | 2,40B | 2,40B | 3,15B | 3,04B | 3,39B |
| Total Debt | 2,52B | 2,75B | 2,55B | 2,45B | 2,38B |
| Cash & Equivalents | 956,00M | 600,89M | 605,38M | 242,49M | 315,47M |
| Current Assets | 1,56B | 1,57B | 1,19B | 982,26M | 1,43B |
| Current Liabilities | 641,15M | 732,19M | 514,70M | 412,75M | 517,07M |